FI911783A0 - Förfarande för framställning av terapeutiskt användbara 4-/3-(4-oxotiazolidinyl)/butynylaminer - Google Patents
Förfarande för framställning av terapeutiskt användbara 4-/3-(4-oxotiazolidinyl)/butynylaminerInfo
- Publication number
- FI911783A0 FI911783A0 FI911783A FI911783A FI911783A0 FI 911783 A0 FI911783 A0 FI 911783A0 FI 911783 A FI911783 A FI 911783A FI 911783 A FI911783 A FI 911783A FI 911783 A0 FI911783 A0 FI 911783A0
- Authority
- FI
- Finland
- Prior art keywords
- butynylamines
- oxothiazolidinyl
- preparation
- therapeutically useful
- therapeutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/509,280 US5034392A (en) | 1990-04-16 | 1990-04-16 | 4-(3-(4-oxothiazolidinyl)butynylamines |
US50928090 | 1990-04-16 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI911783A0 true FI911783A0 (sv) | 1991-04-12 |
FI911783A FI911783A (sv) | 1991-10-17 |
FI94755B FI94755B (sv) | 1995-07-14 |
FI94755C FI94755C (sv) | 1995-10-25 |
Family
ID=24025983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI911783A FI94755C (sv) | 1990-04-16 | 1991-04-12 | Förfarande för framställning av terapeutiskt användbara 4-/3-(4-oxotiazolidinyl)/butynylaminer |
Country Status (26)
Country | Link |
---|---|
US (1) | US5034392A (sv) |
EP (1) | EP0452850B1 (sv) |
JP (1) | JPH07119223B2 (sv) |
KR (1) | KR0163598B1 (sv) |
AR (1) | AR248402A1 (sv) |
AT (1) | ATE163010T1 (sv) |
AU (1) | AU636972B2 (sv) |
BG (1) | BG60066B2 (sv) |
CA (1) | CA2040489C (sv) |
CZ (1) | CZ284447B6 (sv) |
DE (1) | DE69128845T2 (sv) |
DK (1) | DK0452850T3 (sv) |
ES (1) | ES2112844T3 (sv) |
FI (1) | FI94755C (sv) |
GR (1) | GR3026319T3 (sv) |
HU (1) | HUT61017A (sv) |
IE (1) | IE911257A1 (sv) |
IL (1) | IL97852A (sv) |
MX (1) | MX25359A (sv) |
NO (1) | NO300134B1 (sv) |
NZ (1) | NZ237811A (sv) |
PL (1) | PL165488B1 (sv) |
PT (1) | PT97371B (sv) |
RO (1) | RO108683B1 (sv) |
RU (1) | RU2001914C1 (sv) |
ZA (1) | ZA912783B (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5273977A (en) * | 1990-11-05 | 1993-12-28 | Warner-Lambert Company | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
US5147881A (en) * | 1990-11-14 | 1992-09-15 | Pfizer Inc | 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents |
US5130315A (en) * | 1991-01-10 | 1992-07-14 | Raymond R. Wittekind | 1-piperazinyl-2-butenes and -2-butynes |
US5194436A (en) * | 1991-01-10 | 1993-03-16 | Hoechst-Roussel Pharmaceuticals Inc. | 1-piperazinyl-2-butenes and -2-butynes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3354178A (en) * | 1965-04-09 | 1967-11-21 | Sterling Drug Inc | Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides |
ATE81123T1 (de) * | 1987-11-20 | 1992-10-15 | Hoechst Roussel Pharma | 3-(4(1-substituierte-4-piperazinyl)butyl>-4thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel. |
-
1990
- 1990-04-16 US US07/509,280 patent/US5034392A/en not_active Expired - Lifetime
-
1991
- 1991-04-09 BG BG094208A patent/BG60066B2/bg unknown
- 1991-04-12 NZ NZ237811A patent/NZ237811A/en unknown
- 1991-04-12 AR AR91319454A patent/AR248402A1/es active
- 1991-04-12 RO RO147316A patent/RO108683B1/ro unknown
- 1991-04-12 FI FI911783A patent/FI94755C/sv not_active IP Right Cessation
- 1991-04-15 RU SU914895050A patent/RU2001914C1/ru active
- 1991-04-15 DK DK91105972T patent/DK0452850T3/da active
- 1991-04-15 HU HU911239A patent/HUT61017A/hu unknown
- 1991-04-15 MX MX25359A patent/MX25359A/es unknown
- 1991-04-15 CZ CS911065A patent/CZ284447B6/cs not_active IP Right Cessation
- 1991-04-15 KR KR1019910005987A patent/KR0163598B1/ko not_active IP Right Cessation
- 1991-04-15 ZA ZA912783A patent/ZA912783B/xx unknown
- 1991-04-15 AU AU75028/91A patent/AU636972B2/en not_active Ceased
- 1991-04-15 AT AT91105972T patent/ATE163010T1/de not_active IP Right Cessation
- 1991-04-15 DE DE69128845T patent/DE69128845T2/de not_active Expired - Fee Related
- 1991-04-15 CA CA002040489A patent/CA2040489C/en not_active Expired - Fee Related
- 1991-04-15 EP EP91105972A patent/EP0452850B1/en not_active Expired - Lifetime
- 1991-04-15 PT PT97371A patent/PT97371B/pt not_active IP Right Cessation
- 1991-04-15 JP JP3109867A patent/JPH07119223B2/ja not_active Expired - Fee Related
- 1991-04-15 NO NO911465A patent/NO300134B1/no unknown
- 1991-04-15 IE IE125791A patent/IE911257A1/en not_active IP Right Cessation
- 1991-04-15 IL IL9785291A patent/IL97852A/en not_active IP Right Cessation
- 1991-04-15 PL PL91289892A patent/PL165488B1/pl unknown
- 1991-04-15 ES ES91105972T patent/ES2112844T3/es not_active Expired - Lifetime
-
1998
- 1998-03-11 GR GR980400510T patent/GR3026319T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI905941A (sv) | Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat | |
NO179639C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser | |
FI104170B1 (sv) | Förfarande för framställning av terapeutiskt användning 3-aminopyrazolderivat | |
FI890282A0 (sv) | Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat | |
FI880941A (sv) | Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningar | |
NO179283C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler | |
FI96861C (sv) | Förfarande för framställning av terapeutiskt aktiva substituerade indolylpyrrolderivat | |
NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
IS3529A7 (is) | Hliðstæð aðferð við framleiðslu á meðferðarvirkum bis-aza-bísýklískum efnasamböndum | |
NO176758C (no) | Analogifremgangsmåte for fremstilling av terapeutiske anvendbare tetrazolyl-bifenylylmetyl-pyrimidiner | |
FI890245A (sv) | Förfarande för framställning av terapeutiskt användbara 1,4-disubstituerade piperidinylderivat | |
FI930723A0 (sv) | Förfarande för framställning av terapeutiskt aktiva tiazolidinderivat | |
NO180084C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater | |
FI880467A0 (sv) | Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner | |
NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
FI880716A0 (sv) | Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar | |
FI911420A (sv) | Förfarande för framställning av terapeutiskt användbara föreningar | |
NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
FI911701A0 (sv) | Förfarande för framställning av terapeutiskt användbara 2-substituerade-3-karboxikarbapenemer | |
NO177712C (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk virksomme alkylfosfonoseriner | |
EE03027B1 (et) | Meetod 8-klorokinolooni derivaatide valmistamiseks | |
FI911783A (sv) | Förfarande för framställning av terapeutiskt användbara 4-/3-(4-oxotiazolidinyl)/butynylaminer | |
NO177710C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive slektede analoger | |
NO179367C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive fenoksy-heterocykliske forbindelser | |
FI882836A0 (sv) | Förfarande för framställning av terapeutiskt användbar (E)-2-(p-fluorfenetyl)-3-fluorallylamin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
PC | Transfer of assignment of patent |
Owner name: HOECHST MARION ROUSSEL, INC. |
|
MA | Patent expired |